Hyderabad-based startup to begin human clinical trials for India’s first AI-driven antibiotic
SCIINV Develops first AI-driven anti-microbial candidate
SCIINV partners with UK-based Microbira to launch cutting-edge digital diagnostics aimed at combating superbugs in India.
SCIINV Biosciences and UK-Based Microbira Partner to launch Cutting-Edge digital diagnostics to combat superbugs in India. The joint innovation AMRx® and MAAP IR is focused on early and precise pathogen identification, thereby minimizing the misuse of broad-spectrum antibiotics—a major driver of AMR, particularly in high-disease-burden regions like India.
AMRx® Featured in Microsoft Top 200 AI First Movers – Coffee Table Book
Fighting antibiotic resistance Antimicrobial resistance (AMR) is recognized by the World Health Organization (WHO) as one of the top ten global health threats, with severe implications for public health. Alarmingly, every 45 seconds, someone dies from an antibiotic resistant infection. AMRx® platform powered by Azure OpenAI is an advanced, culture-free, AI/ML based urinary tract infection […]